Berlin, October 9, 2024 – Bayer today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for the investigational compound elinzanetant seeking approval for the treatment of…Original Article
U.S. Food and Drug Administration (FDA) Accepts New Drug Application for Elinzanetant
